Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study
Clinical trial NCT04724278 · UNKNOWN
Trial details
- NCT number
- NCT04724278
- Sponsor
- National Jewish Health
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-05
- Primary completion
- 2022-07-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.